RecruitingPhase 2NCT06482684

CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma

Studying Mantle cell lymphoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Christian Schmidt, MD
Principal Investigator
Georg Hess, MD
Johannes Gutenberg University Mainz
Intervention
KTE-X19(drug)
Enrollment
150 target
Eligibility
18-75 years · All sexes
Timeline
2024 – 2031

Study locations (2)

Collaborators

Johannes Gutenberg University Mainz

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06482684 on ClinicalTrials.gov

Other trials for Mantle cell lymphoma

Additional recruiting or active studies for the same condition.

See all trials for Mantle cell lymphoma →

← Back to all trials